Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
4.710
-0.050 (-1.05%)
At close: Nov 20, 2024, 4:00 PM
4.930
+0.220 (4.67%)
After-hours: Nov 20, 2024, 4:35 PM EST
Lipocine Market Cap
Lipocine has a market cap or net worth of $25.19 million as of November 21, 2024. Its market cap has increased by 82.53% in one year.
Market Cap
25.19M
Enterprise Value
5.52M
1-Year Change
82.53%
Ranking
Category
Stock Price
$4.71
Market Cap Chart
Since October 22, 2013, Lipocine's market cap has decreased from $35.00M to $25.19M, a decrease of -28.03%. That is a compound annual growth rate of -2.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 25.50M | 72.30% |
| Dec 29, 2023 | 14.80M | -57.95% |
| Dec 30, 2022 | 35.20M | -59.77% |
| Dec 31, 2021 | 87.50M | -2.02% |
| Dec 31, 2020 | 89.30M | 811.22% |
| Dec 31, 2019 | 9.80M | -64.87% |
| Dec 31, 2018 | 27.90M | -61.73% |
| Dec 29, 2017 | 72.90M | 8.48% |
| Dec 30, 2016 | 67.20M | -71.53% |
| Dec 31, 2015 | 236.00M | 250.67% |
| Dec 31, 2014 | 67.30M | -26.21% |
| Dec 31, 2013 | 91.20M | 160.57% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acurx Pharmaceuticals | 27.13M |
| RenovoRx | 26.87M |
| IGC Pharma | 26.17M |
| Longeveron | 26.13M |
| Athira Pharma | 25.54M |
| Equillium | 25.15M |
| Allurion Technologies | 25.10M |
| Ocean Biomedical | 24.98M |